---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-24-016472"
form_type: "8-K"
ticker: "CBIO"
cik: "0001253689"
company_name: "CRESCENT BIOPHARMA, INC."
filed_at: "2024-12-26T23:59:59+00:00"
generated_at: "2026-05-28T23:12:51.954125+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# GlycoMimetics gets Nasdaq extension to June 16, 2025; stock transferred to Capital Market

## Summary
- Received 180-day extension until June 16, 2025 to meet $1.00 minimum bid price for continued listing.
- Common stock transferred from Nasdaq Global Market to Nasdaq Capital Market effective December 20, 2024.
- If bid price closes at $1.00 or more for 10 consecutive business days before deadline, compliance is achieved.
- Company may consider a reverse stock split to regain compliance; no assurance of success.
- Failure to comply by June 16, 2025 may lead to delisting, subject to appeal.

## SEC filing metadata
- accession: 0001558370-24-016472
- form_type: 8-K
- ticker: CBIO
- cik: 0001253689
- company_name: CRESCENT BIOPHARMA, INC.
- filed_at: 2024-12-26T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1253689/000155837024016472/0001558370-24-016472-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1253689/000155837024016472/glyc-20241219x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-24-016472
- JSON: https://secwatch.observer/filing/0001558370-24-016472.json
- Plain text: https://secwatch.observer/filing/0001558370-24-016472.txt

## Key facts
- Listing & Compliance Notices
  CRESCENT BIOPHARMA, INC. received a nasdaq extension granted notice regarding minimum bid price (rules 5550(a)(2)).
  - Exchange: nasdaq
  - Notice: extension granted
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2)
  source text: December 19, 2024, GlycoMimetics, Inc. (the “ Company ”) received a notice (the “ Extension Notice ”) from the Listing Qualifications Department of the Nasdaq Stock Market (“ Nasdaq ”) informing the Company that Nasdaq granted the Company an additional 180 calendar days, or until June 16, 2025, to regain compliance with the minimum closing bid price requirement for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2) (the “ Rule ”). In connection with the Extension Notice, the listing of the Company’s common stock was transferred from the Nasdaq Global Market to
  evidence_url: https://www.sec.gov/Archives/edgar/data/1253689/000155837024016472/0001558370-24-016472-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.